Pulmatrix Inc (PULM NASDAQ) stock market data APIs
$2.5654
0.05(1.9%)
as of January 30, 2026
Try our APIs with
free plan!
Pulmatrix Inc Financial Data Overview
Price chart is built with
Anychart
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Prev. Close
2.5654
Open
2.6145
High
2.6576
Low
2.5569
52 wk Range
2.146-10.4
Market Cap
9 386 K
Shares Outstanding
3 652 K
Revenue
3 000
EPS
-0.24
Beta
1.673
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pulmatrix Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pulmatrix Inc data using free add-ons & libraries
Get Pulmatrix Inc Fundamental Data
Pulmatrix Inc Fundamental data includes:
- Net Revenue: 3 000
- EBITDA: -6 133 500
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-16
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pulmatrix Inc News
New
Pulmatrix GAAP EPS of -$0.42
* Pulmatrix press release [https://seekingalpha.com/pr/20191009-pulmatrix-announces-second-quarter-2025-financial-results-and-divestment-plan-for-inhalation] (NASDAQ:PULM [https://seekingalpha.com/s...
These 40 Mass. firms made the new Deloitte Fast 500 list
The list, released on Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.
These 40 Mass. companies made the new Deloitte Fast 500 list
The list, released Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.
Pulmatrix appoints Director Anand Varadan
LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
